By Özge ÖzkayaPsychosocial Factors Must Be Taken Into Account When Dealing With Endometriosis
By Özge Özkaya
It is crucial to take into account both physical and psychosocial factors to maintain physical and mental health in patients with endometriosis, according to a new study published in the scientific journal Psychology & Health. “Treatment should address both pelvic…
Key Points Lay Summary
By Nasuhi Engin AydinA herbal product has promising results in experimental endometriosis
By Nasuhi Engin Aydin
Neroli oil (bitter orange) is a nontoxic volatile substance from the flowers of Citrus aurantium that belongs to the Rutaceae family. This oil has notable anti-inflammatory effects besides potent antioxidant activity with 100% singlet oxygen scavenging activity. Contemporary pathophysiological views…
Key Points Lay Summary
By Eylül GÜNExploring a bonafide biomarker to predict endometriosis
By Eylül GÜN
Endometriosis is a complex disease affecting many women in the reproductive age group. As it is important to figure out the mechanisms responsible for the disease, it is also crucial to identify biomarkers that can be used in the diagnosis…
Key Points Lay Summary
By Irem OnurDiagnosis and treatment of endometriosis in adolescents
By Irem Onur
The belief that dysmenorrhea, the primary symptom of endometriosis, in adolescents is an inevitable condition seen in menstruation as well as unwillingness to perform diagnostic laparoscopy may cause the delay of diagnosis of endometriosis. This is according to a recent…
Key Points Lay Summary
A hope for postoperative symptomatic endometriosis therapy
By Irem Onur
A new chapter in the treatment of symptomatic endometriosis patients may begin since new medical approaches including oral GnRH antagonists, selective progesterone receptor modulators, aromatase inhibitors, and peritoneal immune response modulators are being actively evaluated. To date, there was only…
Key Points Lay Summary
By Yu YuOxidative stress leads to elevated cytokines, excessive structural damage and angiogenesis
By Yu Yu
Endometriosis is characterized by elevated intracellular reactive oxygen species, which is then believed to upregulate inflammatory cytokines. Reactive oxygen species also regulate the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), which is closely linked with immune responses.…
Key Points Lay Summary
By Selma OransayA position statement of diagnosing and treating endometriosis for gynecologists.
By Selma Oransay
Endometriosis Treatment Italian Group recently declared 10 "valuable" conducts to evaluate endometriotic patients and published them in Hum. Reprod. Open. This society consists of 16 university departments and training center with expert clinicians on endometriosis from Italy. After arising the idea of…
Key Points Lay Summary
Endometriosis as a chronic disease: The benefits for the patients
By Selma Oransay
Rebecca O'Hara et al. from Monash University, Melbourne, Australia, recently published their qualitative case study in the Journal "Australian Health Review", to build a National Policy about endometriosis considering as a chronic disease. In Australia, long-term complex diseases are managed…
Key Points Lay Summary
How are endometriosis patients managed clinically?
By Irem Onur
This review paper by Falcone and Flyckt, entitled “Clinical Management of Endometriosis” published in the journal Obstetrics & Gynecology aims to summarize the current strategies for treating endometriosis patients with pain, pelvic dysfunction, and subfertility related to their disease. There are many…
Key Points Lay Summary
By Hale Goksever CelikThe comparison of Chinese women in terms of risk factors, genetics and treatment of endometriosis
By Hale Goksever Celik
Endometriosis is characterized by endometrial implants outside of the uterine cavity. There is a wide spectrum of symptoms of this disease including dysmenorrhea, chronic pelvic pain, dyspareunia, extragenital symptoms. The pathogenesis of endometriosis appears to be multifactorial, including ectopic endometrial…
Key Points Lay Summary
By Vishaan NurseyArcyriaflavin A Decreases Endometriosis Cell Viability and Proliferation
By Vishaan Nursey
The purpose of this research topic was to determine whether Arcyriaflavin A could serve as a potential new therapeutic option for those suffering from Endometriosis. Arcyriaflavin A is a Cyclin D1 inhibitor. Cyclin D1 regulates the cell cycle by interacting…
Key Points Lay Summary
By Elisabetta KuhnReevaluating response and failure of medical treatment of endometriosis
By Elisabetta Kuhn
Endometriosis is a chronic disease affecting more than 10% of women in the fertile age and causing "pain" symptoms, that may require medical therapy. Most medical treatments used for endometriosis exert a hormonal mechanism to curtail estrogen effects either locally…
Key Points Lay Summary